Jagsonpal Pharmaceuticals’ Q2 FY27 Consolidated Revenue Rises 29% To ₹964 Crore

Mumbai: Jagsonpal Pharmaceuticals Limited on Tuesday announced its unaudited financial results for the quarter and half year ended 30 September 2026, reporting a consolidated revenue increase of 29% to ₹964 crore for Q2 FY27.Standalone PerformanceFor the standalone business, Q2 FY27 revenue from operations grew by 9.3% year-on-year to ₹814 crore. Standalone EBITDA for the quarter was ₹185 crore, with an...